Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02454036 · ClinicalTrials.gov registry record · Phase 2
Biobehavioral Intervention in Gynecologic Oncology Patients
A Phase 2 study, sponsored by Rachel Miller.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT02454036: Completed Phase 2 study, sponsored by Rachel Miller.
NCT02454036 is a Phase 2 study that has completed, run by Rachel Miller. The registered enrollment target is 6 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02454036, a Phase 2 study, has completed, sponsored by Rachel Miller.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
Baseline self-report outcome measures will be completed and additional assessments will occur mid-treatment , post-treatment , 3 months following completion of all sessions, and 6 months following completion of all sessions. Patients and therapists will complete the evaluation measures in private (at home, in an office). At the University of Kentucky Markey Cancer Center, BBI treatment is offered in group and individual formats. The course of individual treatment varies and group treatment consists of 10 1.5-hour weekly sessions in the "intensive" phase, followed by 2 1.5-hour bi-weekly maintenance sessions. Individual treatment is one-on-one. In group treatment, there are typically 6-12 patients per group and 1 or 2 therapists. The intervention helps patients to learn adaptive coping strategies and how to apply them to daily stressors. Additional content discusses use of seeking information, enhancing social support, enhancing body esteem and intimacy, and maintaining positive changes.
Interventions
- BEHAVIORAL BBI intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-05-18 |
| Phase | Phase 2 |
What the finished NCT02454036 record still lists
NCT02454036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which BBI intervention is the first listed.
NCT02454036 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02454036 about?
NCT02454036 is a clinical study titled "Biobehavioral Intervention in Gynecologic Oncology Patients". Baseline self-report outcome measures will be completed and additional assessments will occur mid-treatment , post-treatment , 3 months following completion of all sessions, and 6 months following completion of all sessions. Patients and therapists will complete the evaluation measures in private (a...
What is the current status of trial NCT02454036?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2015-06. Estimated completion is 2017-05-18.
What interventions are being tested in trial NCT02454036?
The interventions under investigation include: BBI intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02454036?
This trial is sponsored by Rachel Miller, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02454036's enrollment target sits among peer trials
6 1996th of 2000 higher than 1 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia